K. Iyonaga

发表

Use of tacrolimus, a potent antifibrotic agent, in bleomycin-induced lung fibrosis

M. Suga, H. Kohrogi, A. Yamashita, 2006, European Respiratory Journal.

ALTERATIONS IN CYTOKERATIN EXPRESSION BY THE ALVEOLAR LINING EPITHELIAL CELLS IN LUNG TISSUES FROM PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

M. Suga, K. Iyonaga, M. Miyajima, 1997, The Journal of pathology.

Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation

M. Suga, J. Nagano, K. Iyonaga, 2005, Clinical Diagnostic Laboratory Immunology.

Production of fibroblast proliferative cytokines from T lymphocytes stimulated by a B cell lymphoma line and their functional heterogeneity.

M. Hirashima, M. Ando, M. Matsumoto, 1994, Immunology letters.

Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.

T. Akaike, M. Suga, K. Iyonaga, 2000, American journal of respiratory and critical care medicine.

Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases.

M. Ando, T. Yoshimura, M. Takeya, 1994, Human pathology.

Pneumocyte Biomarkers KL-6 and Surfactant Protein D Reflect the Distinct Findings of High-Resolution Computed Tomography in Nonspecific Interstitial Pneumonia

M. Suga, H. Kohrogi, K. Ichikado, 2011, Respiration.

Hyperoxia-induced diffuse alveolar damage in pigs: correlation between thin-section CT and histopathologic findings.

N. Müller, J. Ikezoe, O. Honda, 2000, Radiology.

Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.

M. Suga, K. Iyonaga, H. Ichiyasu, 1999, The European respiratory journal.

Morphological Alteration of Cultured Tracheobronchial Epithelial Cells is Accompanied by the Expression of Chemokines, MCP‐1 and CINC/gro, in Rats

M. Suga, M. Takeya, K. Iyonaga, 1998, International journal of experimental pathology.

[Idiopathic interstitial pneumonia associated with a high level of CA19-9 in serum and with CA19-9 in lung tissue].

M. Suga, M. Ando, K. Iyonaga, 1997, Nihon Kyobu Shikkan Gakkai zasshi.

Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater

Y. Tomita, K. Kashiwabara, T. Sakagami, 2020, International Journal of Clinical Oncology.

Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury.

M. Suga, K. Ichikado, K. Iyonaga, 2001, The European respiratory journal.

A Case of Small Cell Lung Cancer in a Patient with Rheumatoid Arthritis Under Anti-TNF Therapy

K. Iyonaga, T. Matsuoka, Chieko Yoshida, 2013 .

[Clinical analysis of the acute exacerbation in patients with idiopathic pulmonary fibrosis].

M. Suga, Keizo Sato, H. Kohrogi, 2006, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis.

M. Suga, Taro Yamamoto, K. Iyonaga, 1999, The European respiratory journal.

Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis.

M. Suga, K. Iyonaga, H. Ichiyasu, 1998, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

A novel monoclonal antibody, RM-4, specifically recognizes rat macrophages and dendritic cells in formalin-fixed, paraffin- embedded tissues

M. Takeya, Kiyoshi Takahashi, M. Ando, 1997, The Histochemical Journal.

The Role of Dendritic Cells in Granuloma Formation

M. Suga, K. Iyonaga, K. Kawamura, 2005 .

Dendritic cells and the regulation of a granulomatous immune response in the lung.

E. Schneeberger, K. Iyonaga, K. McCarthy, 2002, American journal of respiratory cell and molecular biology.

Absence of gallium uptake in unicentric and multicentric Castleman's disease.

I. Okamoto, M. Matsumoto, M. Suga, 2003, Internal medicine.

Multicentric Castleman's disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide.

M. Suga, K. Ichikado, K. Iyonaga, 2003, Internal medicine.

A superfemale with primary Sjögren's syndrome which involved systemic organs

M. Suga, K. Iyonaga, M. Ando, 1997, Journal of internal medicine.

Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats.

M. Takeya, Y. Natori, K. Iyonaga, 1997, The Journal of laboratory and clinical medicine.

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)

T. Hirai, T. Johkoh, N. Higashi, 2023, BMC Pulmonary Medicine.

Role of monocyte chemoattractant protein‐1 in Propionibacterium acnes–induced pulmonary granulomatosis

M. Suga, K. Iyonaga, H. Ichiyasu, 2001, Microscopy research and technique.

Involvement of the central nervous system in rheumatoid arthritis: its clinical manifestations and analysis by magnetic resonance imaging.

Y. Ando, M. Uchino, E. Uyama, 1995, Internal medicine.

Production of monocyte chemoattractant protein-1 by cultured glomerular epithelial cells: inhibition by dexamethasone.

M. Takeya, Y. Natori, M. Kawakami, 1997, Experimental nephrology.